The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PRME FINANCIAL STATEMENTS

Prime Medicine, Inc. Common Stock — balance sheet, income statement and cash flow trends

PRMEPrime Medicine, Inc. Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M02020202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue4.1 M $Gross Profit-41.8 M $ · -1026%Operating Income-196.5 M $ · -4825%Pre-tax Income-187.9 M $ · -4613%Net Income to Owners-187.9 M $ · -4613%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue4.1 M $-17.9%
Gross Profit-41.8 M $-1,448.8%
Operating Income-196.5 M $—
EBITDA-180.5 M $—
Net Income to Owners-187.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M2020202120222023202420252026

Capital Structure

Q2 2026
Total Assets249 M
  • Equity39.8 M $16%
  • Current Liabilities31.7 M $13%
  • Long-term Liabilities177.5 M $71%

Key Figures

YoY change
Total Assets249 M $-10.7%
Total Liabilities209.2 M $-4.1%
Total Equity39.8 M $-34.6%
Cash & ST Investments95.1 M $-6.6%
Total Debt112.5 M $-6.1%
Net Debt65 M $-1.4%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M02020202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-150 M-100 M-50 M0-159 M $Operating3.6 M $Investing145.7 M $Financing-9.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-159 M $—
Capital Expenditures797 K $-88.7%
Free Cash Flow-159.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PRME

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.